Equitable distribution in rare indications for liver transplantation: the dilemma of the too small tablecloth continues!
Corresponding Author
Andreas A. Schnitzbauer
Clinic for General and Visceral Surgery, Frankfurt University Hospital, Goethe-University Frankfurt, Frankfurt/Main, Germany
Correspondence
Andreas A. Schnitzbauer, MD, FACS, FEBS, Clinic for General and Visceral Surgery, Frankfurt University Hospital, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt/Main, Germany.
Tel.: +49-69-6301-5253;
fax: +49-69-6301-84028;
e-mail: [email protected]
Search for more papers by this authorWolf O. Bechstein
Clinic for General and Visceral Surgery, Frankfurt University Hospital, Goethe-University Frankfurt, Frankfurt/Main, Germany
Search for more papers by this authorCorresponding Author
Andreas A. Schnitzbauer
Clinic for General and Visceral Surgery, Frankfurt University Hospital, Goethe-University Frankfurt, Frankfurt/Main, Germany
Correspondence
Andreas A. Schnitzbauer, MD, FACS, FEBS, Clinic for General and Visceral Surgery, Frankfurt University Hospital, Goethe University Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt/Main, Germany.
Tel.: +49-69-6301-5253;
fax: +49-69-6301-84028;
e-mail: [email protected]
Search for more papers by this authorWolf O. Bechstein
Clinic for General and Visceral Surgery, Frankfurt University Hospital, Goethe-University Frankfurt, Frankfurt/Main, Germany
Search for more papers by this author
References
- 1Markus BH, Dickson ER, Grambsch PM, et al. Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med 1989; 320: 1709.
- 2Singal AK, Fang X, Kaif M, et al. Primary biliary cirrhosis has high wait-list mortality among patients listed for liver transplantation. Transpl Int Off J Eur Soc Organ Transplant 2016; 30: 454.
- 3Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: from “cirrhosis” to “cholangitis”. Hepatol Baltim Md 2015; 62: 1620.
- 4Persad G, Wertheimer A, Emanuel EJ. Principles for allocation of scarce medical interventions. Lancet Lond Engl 2009; 373: 423.
- 5Genda T, Ichida T, Sakisaka S, et al. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system. J Gastroenterol 2014; 49: 324.
- 6Adam R, McMaster P, O'Grady JG, et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc 2003; 9: 1231.
- 7Kashyap R, Safadjou S, Chen R, et al. Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases–an analysis of the UNOS database. J Gastrointest Surg Off J Soc Surg Aliment Tract 2010; 14: 1362.
- 8Floreani A, Franceschet I, Perini L, Cazzagon N, Gershwin ME, Bowlus CL. New therapies for primary biliary cirrhosis. Clin Rev Allergy Immunol 2015; 48: 263.
- 9 European Association for the Study of the Liver. EASL clinical practice guidelines: management of cholestatic liver diseases. J Hepatol 2009; 51: 237.
- 10Nevens F, Andreone P, Mazzella G, et al. A placebo-controlled trial of obeticholic acid in primary biliary cholangitis. N Engl J Med 2016; 375: 631.
- 11Branger P, Samuel U. Eurotransplant Annual Report 2015. www.eurotransplant.org. 2015.
